Journal Information
Vol. 39. Issue 2.
Pages 74-80 (February 2003)
Share
Share
Download PDF
More article options
Vol. 39. Issue 2.
Pages 74-80 (February 2003)
Full text access
Uso secuencial de la pulsioximetría nocturna y la poligrafía respiratoria (AutoSet®) para el diagnóstico del síndrome de apneas-hipopneas durante el sueño en pacientes con alta sospecha clínica
Sequential use of nocturnal pulse oximetry and respiratory polygraphy (AutoSet®) for diagnosing sleep apnea/hypopnea syndrome in high risk patients
Visits
11554
M.A. Martínez Garcíaa,
Corresponding author
med013413@nacom.es

Correspondencia: Unidad de Neumología. Servicio de Medicina Interna. Hospital General de Requena.Paraje Casa Blanca, s/n. 46340 Requena. Valencia. España
, J.J. Soler Cataluñab, P. Román Sánchezb
a Unidad de Neumología. Hospital General de Requena. Valencia
b Servicio de Medicina Interna. Hospital General de Requena. Valencia. España
This item has received
Article information
Abstract
Bibliography
Download PDF
Statistics
Objetivo

Construcción de un algoritmo para el diagnós-tico del síndrome de apneas-hipopneas durante el sueño (SAHS) mediante el uso optimizado y secuencial de la pul-sioximetría nocturna (PN) y la poligrafía respiratoria AutoSet® (AS) en pacientes con alta sospecha clínica de SAHS

Métodos

Realización simultánea de una PN y AS en 145 pacientes con alta sospecha clínica de SAHS (al menos dos de: roncopatía crónica, apneas presenciadas y repetidas, y somnolencia diurna patológica). El diagnóstico de SAHS se realizó con un índice de apneas-hipopneas (IAH) (obtenido mediante AS)=10. Para la construcción del algoritmo diag-nóstico se siguieron los siguientes pasos: cálculo de la preva-lencia de SAHS; cálculo del mejor punto de corte diagnósti-co en el índice de desaturaciones mayores o iguales al 4% (ID 4%) respecto al IAH; análisis del valor predictivo positi-vo (VPP) y negativo (VPN) para dicho valor y correlación y concordancia entre ID 4% e IAH según la existencia y gra-vedad de SAHS

Resultados

La prevalencia global de SAHS fue del 83,4%. El mejor punto de corte se obtuvo para un ID 4%=10 (sensibilidad [S]: 82%; especificidad [E]: 83%). Los VPP y VPN para la prevalencia calculada fueron de 0,95 y 0,29, respectivamente. La correlación y concordancia global entre el ID 4% e IAH fue de 0,84 y 0,93, respectivamente. En pa-cientes sin SAHS fueron de 0,49 y 0,35, y ambas aumenta-ron progresivamente en SAHS leves, moderados y graves (0,90 y 0,95, respectivamente, en SAHS graves). Con todos estos datos se construyó el algoritmo diagnóstico según el cual la obtención de un ID 4% =30 en la PN (S: 72%; E: 100%) evitaría la realización de una AS posterior, mientras que un ID 4% < 30 haría necesaria la realización de estudios posteriores (AS o PSG en caso de negatividad de la AS), dada la alta prevalencia de SAHS en nuestra serie

Conclusiones

La utilización secuencial de la PN y la AS permite ahorrar un número importante de estudios polisom-nográficos en poblaciones con alta sospecha clínica de SAHS

Palabras clave:
Síndrome de apneas-hipopneas durante el sue-ño
AutoSet®
Pulsioximetría nocturna
Algoritmo diagnóstico
Objective

To construct an algorithm for the diagnosis of sleep apnea/hypopnea syndrome (SAHS) based on the opti-mized sequential use of nocturnal pulse oximetry and respi-ratory polygraphy (AutoSet®, AS) in patients suspected of SAHS

Methods

Simultaneous performance of pulse oximetry and AS in 145 patients highly suspected of SAHS (at least two of the following signs or symptoms: chronic snoring, ob-servations of repeated apneic events, and abnormal daytime drowsiness). SAHS was diagnosed when the apnea/hypopnea index (AHI) was greater than or equal to 10, based on AS findings. The diagnostic algorithm was obtained by calcula-ting the prevalence of SAHS, calculating the best diagnostic cutoff point for a desaturation index greater than or equal to 4% (ID4%) based on the AHI; analyzing the positive predic-tive value (PPV) and negative predictive value (NPV) for the cutoff and the correlation and agreement between ID4% and the AHI depending on the presence and severity of SAHS

Results

The overall prevalence of SAHS was 83.4%. The best cutoff point was obtained using ID4% greater than or equal to 10 (sensitivity 82%; specificity 83%). The PPV and NPV for the prevalence calculated were 0.95 and 0.29, respectively. The correlation between ID4% and AHI was 0.84; overall agreement was 0.93. For patients who did not have SAHS, the PPV was 0.49, and the NPV was 0.35; both gradually increased in cases of mild, moderate and severe SAHS (to 0.90 and 0.95, respectively, for severe SAHS). Using these data we created a diagnostic algorithm accor-ding to which an ID4% greater than or equal to 30 for noc-turnal pulse oximetry (sensitivity 72%, specificity 100%) would indicate that AS testing would be unnecessary. An ID4% less than 30, on the other hand, would lead to further testing (AS, or polysomnography in the event of a negative AS), based on the high prevalence of SAHS in our series

Conclusions

The sequential use of nocturnal pulse oxi-metry and AS allows substantial savings of polysomnograp-hic testing in groups at high risk of SAHS

Keywords:
Sleep apnea-hypopnea syndrome
AutoSet®
Nocturnal pulse oximetry
Diagnostic algorithm
Full text is only aviable in PDF
Bibliografía
[1.]
D.E. Phillipson.
Sleep apnea. A major public health problem.
N Engl J Med, 328 (1993), pp. 1271-1273
[2.]
T. Young, M. Palta, J. Dempsey, J. Skatrud, S. Weber, S. Bard.
The occurrence of sleep disorders breathing among middle aged adults.
N Engl J Med, 328 (1993), pp. 1230-1236
[3.]
J. Durán, S. Esnaola, R. Rubio, I. Toña, C. Egea, G. De La Torre, et al.
Prevalence of obstructive sleep apnea in the general male population of Vitoria-Gasteiz (Spain).
Am J Resp Crit Care Med, 155 (1997), pp. 844
[4.]
J.M. Marín, J.M. Gascón, S. Carrizo, J. Gispert.
Prevalence of sleep apnoea syndrome in the Spanish adult population.
International J Epidemiol, 26 (1997), pp. 381-386
[5.]
F. Barbé, J. Pericás, A. Muñoz, L. Findley, J.M. Antó, A.G.N. Agustí.
Automobile accident in patients with sleep apnea syndrome.
Am J Respir Crit Care Med, 158 (1998), pp. 18-22
[6.]
J. Terán-Santos, A. Jiménez-Gómez, J. Cordero-Guevara.
The association between sleep apnea and the risk of traffic accidents.
N Engl J Med, 340 (1999), pp. 847-851
[7.]
J. Hung, E.G. Whitford, R.W. Parsons, D.R. Hilman.
Association of sleep apnoea with myocardial infarction in man.
Lancet, 336 (1990), pp. 261-264
[8.]
F. García-Río, M.A. Racionero, J.M. Pino, I. Martínez, F. Ortuño, C. Villasante, et al.
Sleep apnea and hypertension. The role of peripheral chemoreceptors and the sympathetic system.
Chest, 117 (2000), pp. 1417-1425
[9.]
J. He, M.H. Kryger, F.J. Zorich, W. Conway, T. Roth.
Mortality and apnea index in obstructive sleep apnea: experience in 358 male patients.
Chest, 94 (1988), pp. 9-14
[10.]
M. Partinen, C. Guilleminault.
Mortality of patients with obstructive sleep apnea syndrome: a follow up study.
Chest, 94 (1988), pp. 1200-1204
[11.]
E. Sharar, C.W. Whitney, S. Redline, E.T. Lee, A.B. Newman, F.J. Nieto, et al.
Sleep-disordered breathing and cardiovascular disease. Cross-sectional results of the Sleep Heart Health Study.
Am J Respir Crit Care Med, 163 (2001), pp. 19-25
[12.]
P.J. Ryan, M.F. Hilton, D.A.R. Boldy, A. Evans, S. Bradbury, S. Sapiano, et al.
Validation of British Thoracic Society guidelines for the diagnosis of the sleep apnea/hypopnea syndrome: can polysomnography be avoided?.
Thorax, 50 (1995), pp. 972-975
[13.]
E.M. García Días, F. Capote Gil, A. Cano Gómez, A. Sánchez Armengol, C. Carmona Bernal, J.G. Soto Campos.
Poligrafía respiratoria en el diagnóstico del síndrome de apneas obstructivas durante el sueño.
Arch Bronconeumol, 33 (1997), pp. 69-73
[14.]
J.M. Monserrat, J. Amilibia, F. Barbé, F. Capote, J. Durán, N.G. Mangado, et al.
Tratamiento del síndrome de las apneas-hipopneas durante el sueño.
Arch Bronconeumol, 34 (1998), pp. 204-206
[15.]
H.M. Engleman, R.N. Kingshott, P.K. Wraith, T.W. Mackay, J.J. Deary, N.J. Douglas.
Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnea/hipopnea syndrome.
Am J Respir Crit Care Med, 159 (1999), pp. 461-467
[16.]
E. Ballester, J.R. Badía, L. Hernández, E. Carrasco, J. De Pablo, C. Fornas, et al.
Evidence of the effectiveness of continuous positive airway pressure in the treatment of sleep apnea/hypopnea syndrome.
Am J Respir Crit Care Med, 159 (1999), pp. 495-501
[17.]
F. Sériès, I. Marc, Y. Cormier, J. La Forge.
Utility of nocturnal home oximetry for case finding in patients with suspected sleep apnea hypopnea syndrome.
Ann Intern Med, 119 (1993), pp. 449
[18.]
A.L. Chesson, R.A. Ferber, J.H. Fry, M. Grigg-Damberger, K.M. Hartse, T.D. Hurwitz, et al.
ASDA Standards of Practice Commitee. Practice parameters for the indications for polysomnography and related procedures.
Sleep, 20 (1997), pp. 406-422
[19.]
P. Lévy, J.L. Pépin, C. Deschaux-Blanc, S. Paramelle, C. Brambilla.
Accuracy of oximetry for detection of respiratory disturbances in sleep apnea syndrome.
Chest, 109 (1996), pp. 395-399
[20.]
E. Chiner, J. Signes-Costa, J.M. Arriero, J. Marco, I. Fuentes, A. Sergado.
Nocturnal oximetry for the diagnosis of the sleep apnea hypopnea syndrome: a method to reduce the number of polysomnographies?.
Thorax, 54 (1999), pp. 968-971
[21.]
T. Verse, W. Pirsig, B. Junge-Hülsing, B. Kroker.
Validation of the POLY-MESAM seven-channel ambulatory recording unit.
Chest, 117 (2000), pp. 1613-1618
[22.]
R. Ferber, R. Millman, M. Coppola.
ASDA standards of practice: practice parameters for the use of portable recording in the assessment of obstructive sleep apnea.
Sleep, 17 (1994), pp. 378-392
[23.]
P. Mayer, J.C. Meurice, F. Philip-Joet, A. Cornette, D. Rakotonanahary, N. Meslier, et al.
Simultaneous laboratory-based comparison of ResMed Autoset with polysomnography in the diagnosis of sleep apnea/hypopnea syndrome.
Eur Respir J, 12 (1998), pp. 770-775
[24.]
P.A. Bradley, I.L. Mortimore, N.J. Douglas.
Comparison of polysomnography with ResCare Autoset in the diagnosis of the sleep apnea/ hypopnea syndrome.
Thorax, 50 (1995), pp. 1201-1203
[25.]
J.L. Kiely, C. Delahunty, S. Matthews, W.T. McNicholas.
Comparison of a limited computerized diagnostic system (ResCare Autoset) with polysomnography in the diagnosis of obstructive sleep apnea syndrome.
Eur Respir J, 9 (1998), pp. 2360-2364
[26.]
M. Gugger.
Comparison of ResMed AutoSet (version 3.03) with polysomnography in the diagnosis of the sleep apnea/hypopnea syndrome.
Eur Respir J, 10 (1997), pp. 587-591
[27.]
M. Gugger, J. Mathis, C. Bassetti.
Accuracy of an intelligent CPAP machine with in-built diagnostic abilities in detecting apneas: a comparison with polysomnography.
Thorax, 50 (1995), pp. 1199-1201
[28.]
B. Fleury, D. Rakotonanahary, C. Hausser Hauw, B. Lebeau, C. Guilleminault.
A laboratory validation study of the diagnostic mode of the Autoset system for sleep-related respiratory disorders.
Sleep, 19 (1996), pp. 502-505
[29.]
K. Rees, P.K. Wraith, M. Berthon-Jones, N.J. Douglas.
Detection of apneas, hipopneas and arousals by the AutoSet in the sleep apnea/ hypopnea syndrome.
Eur Respir J, 12 (1998), pp. 764-769
[30.]
E. Chiner, J. Arriero, J. Signes-Costa, J. Marco, I. Fuentes.
Validación de la version española del test de somnolencia Epworth en pacientes con síndrome de apnea de sueño.
Arch Bronconeumol, 35 (1999), pp. 422-427
[31.]
R.A. Pauwels, A.S. Buist, P.M. Carveley, C.R. Jenkins, S.S. Hurd.
Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for chronic obstructive lung disease (GOLD) Workshop Summary.
Am J Respir Crit Care Med, 163 (2001), pp. 1256-1276
[32.]
R. Kessler, A. Chaouat, P. Schinkevich, M. Faller, S. Casel, J. Krieger, et al.
The obesity-hypoventilation syndrome revisited.
Chest, 120 (2001), pp. 369-376
[33.]
C. Hoch, C.F. Reynolds, T.H. Monk.
Comparison of sleep disordered breathing among healthy elderly in the seventh, eighth, and ninth decades of life.
Sleep, 13 (1990), pp. 502-508
Copyright © 2003. Sociedad Española de Neumología y Cirugía Torácica
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?